铁木制药 IRWD
$4.39 +$0.36 (+8.93%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $4.36 -0.68%
开盘$4.26
昨收$4.03
当日区间$4.10 – $4.44
成交量3.96M
市值$726.77M
市盈率(TTM)4.9
股息率–
股权结构与仓位
谁在持有、谁在做空,以及大资金的流向
机构持股比例98.8%-1.38 个百分点,较上季度
持仓机构数264+5 ,较上季度
内部人近期交易29次买入 / 21次卖出净买入
空头持仓比例9.61% 占流通股回补天数 8.0 · 截至 15 Oct 2026
卖空成交量占比17.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入,近20个交易日
大单买入减卖出的净额(美元)。该窗口期内:−$1.72M(5个净流入日,15个净流出日)。
按单量净流入,近20个交易日
超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。
已披露的前五大股东合计持有35.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从10.05%降至9.61%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| CWA Asset Management Group, LLC | Mutual Fund | 2026/Q3 | +208,277 | 0.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +313,518 | 0.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +4,425,627 | 10.8% |
| Mackenzie Financial Corporation | Mutual Fund | 2026/Q3 | +1,807,459 | 1.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,352,657 | 5.3% |
| Wells Fargo & Company | Public Company | 2026/Q3 | +1,147,348 | 0.7% |
| Morgan Stanley | Public Company | 2026/Q3 | +1,039,251 | 0.9% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +619,531 | 0.8% |
| Hudson River Trading LLC | Private Company | 2026/Q3 | +577,337 | 0.3% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +562,759 | 4.6% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +440,836 | 1.5% |
| Jacobs Levy Equity Management Inc | Mutual Fund | 2026/Q3 | +433,487 | 2.5% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +384,127 | 0.3% |
| Voya Investment Management LLC | Mutual Fund | 2026/Q3 | +338,631 | 0.3% |
| O'Shaughnessy Asset Management, LLC | Mutual Fund | 2026/Q3 | +310,668 | 0.3% |
按报告期列出的机构买卖动态,变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 23 Sep 2026 | Michael Shetzline | Former Chief Medical Officer, Senior VP and Head of Research & Drug Development | Intent to Sell (Form 144) | -83,306 | $4.53 | – |
| 14 Sep 2026 | Alexander Denner | Independent Director | Other Acquisition | +3,694 | – | 327,549 |
| 19 Jul 2026 | Jeffrey Silber | Chief Medical Officer, Head of Research & Drug Development | Other Acquisition | +137,036 | – | 137,036 |
| 6 Jul 2026 | Ronald Silver | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer | Automatic Disposition | -127,890 | $4.52 | 2,235 |
| 15 Jun 2026 | Jay Shepard | Independent Director | Other Acquisition | +63,481 | – | 235,036 |
| 15 Jun 2026 | Mark Currie | Independent Director | Other Acquisition | +63,481 | – | 676,900 |
| 15 Jun 2026 | Catherine Moukheibir | Independent Director | Other Acquisition | +63,481 | – | 181,425 |
| 15 Jun 2026 | Julie McHugh | Independent Chairperson | Other Acquisition | +63,481 | – | 250,749 |
| 15 Jun 2026 | Julie McHugh | Independent Chairperson | Automatic Disposition | -21,571 | $3.73 | 250,749 |
| 15 Jun 2026 | Marla Kessler | Independent Director | Other Acquisition | +63,481 | – | 229,364 |
| 15 Jun 2026 | Jon Duane | Independent Director | Other Acquisition | +63,481 | – | 253,820 |
| 15 Jun 2026 | Alexander Denner | Independent Director | Other Acquisition | +67,546 | – | 323,855 |
| 18 May 2026 | Ronald Silver | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer | Other Acquisition | +25,000 | – | 311,445 |
| 16 Mar 2026 | Sarissa Capital Management LP | Open Market Disposition | -6,730,800 | $3.31 | 9,188,635 | |
| 12 Mar 2026 | Alexander Denner | Independent Director | Other Acquisition | +4,451 | – | 256,309 |
| 9 Mar 2026 | Thomas McCourt | Chief Executive Officer | Other Acquisition | +409,836 | – | 1,038,128 |
| 9 Mar 2026 | Michael Shetzline | Former Chief Medical Officer, Senior VP and Head of Research & Drug Development | Other Acquisition | +136,612 | – | 281,293 |
| 9 Mar 2026 | Ronald Silver | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer | Other Acquisition | +163,934 | – | 286,445 |
| 9 Mar 2026 | John Minardo | Chief Legal Officer | Other Acquisition | +136,612 | – | 271,868 |
| 9 Mar 2026 | Gregory Martini | Former Senior VP, CFO & Investor Relations | Other Acquisition | +136,612 | – | 219,945 |
数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。
空头持仓(按报告期)
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 15,887,553 | 9.6% | 8.0 |
| 30 Sep 2026 | 15,567,942 | 9.4% | 6.2 |
| 15 Sep 2026 | 18,728,986 | 11.3% | 13.1 |
| 31 Aug 2026 | 17,654,677 | 10.7% | 11.9 |
| 14 Aug 2026 | 18,066,382 | 10.9% | 6.4 |
| 31 Jul 2026 | 16,542,403 | 10.0% | 10.0 |
暂无评论——快来第一个聊聊 IRWD。
登录后参与讨论。